Ensho Therapeutics is a startup based in the United States.
Ensho Therapeutics is a company headquartered in the United States.
Ensho Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule therapies targeting α4β7 integrin for the treatment of inflammatory bowel disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.